Literature DB >> 12111810

Extracellular proteolysis in brain injury and inflammation: role for plasminogen activators and matrix metalloproteinases.

Eng H Lo1, Xiaoying Wang, M Louise Cuzner.   

Abstract

The role of intracellular proteases (e.g., calpains and caspases) in the pathophysiology of neuronal cell death has been extensively investigated. More recently, accumulating data have suggested that extracellular proteolysis also plays a critical role. The two major systems that modify the extracellular matrix in brain are the plasminogen activator (PA) and matrix metalloproteinase (MMP) axes. This Mini-Review delineates major pathways of PA and MMP action after stroke, brain trauma, and chronic inflammation. Deleterious effects include the disruption of blood-brain barrier integrity, amplification of inflammatory infiltrates, demyelination, and possibly interruption of cell-cell and cell-matrix interactions that may trigger cell death. In contrast, PA-MMP actions may contribute to extracellular proteolysis that mediates parenchymal and angiogenic recovery after brain injury. As the mechanisms of deleterious vs. potentially beneficial PA and MMP actions become better defined, it is hoped that new therapeutic targets will emerge for ameliorating the sequelae of brain injury and inflammation. Copyright 2002 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12111810     DOI: 10.1002/jnr.10270

Source DB:  PubMed          Journal:  J Neurosci Res        ISSN: 0360-4012            Impact factor:   4.164


  83 in total

Review 1.  Contribution of extracellular proteolysis and microglia to intracerebral hemorrhage.

Authors:  Jian Wang; Stella E Tsirka
Journal:  Neurocrit Care       Date:  2005       Impact factor: 3.210

2.  Apocynum venetum leaf extract attenuates disruption of the blood-brain barrier and upregulation of matrix metalloproteinase-9/-2 in a rat model of cerebral ischemia-reperfusion injury.

Authors:  Jun Xiang; Rui Lan; Yu-Ping Tang; Yi-Ping Chen; Ding-Fang Cai
Journal:  Neurochem Res       Date:  2012-05-17       Impact factor: 3.996

3.  Annexin A2: a tissue plasminogen activator amplifier for thrombolytic stroke therapy.

Authors:  Xiang Fan; Zhanyang Yu; Jianxiang Liu; Ning Liu; Katherine A Hajjar; Karen L Furie; Eng H Lo; Xiaoying Wang
Journal:  Stroke       Date:  2010-10       Impact factor: 7.914

4.  Dl-3-n-butylphthalide Attenuates Spinal Cord Injury via Regulation of MMPs and Junction Proteins in Mice.

Authors:  Binbin Zheng; Yanjun Jin; Shuang Mi; Wei Xu; Xiangdong Yang; Zhenghua Hong; Zhangfu Wang
Journal:  Neurochem Res       Date:  2021-06-04       Impact factor: 3.996

5.  The extracellular protease matrix metalloproteinase-9 is activated by inhibitory avoidance learning and required for long-term memory.

Authors:  Vanja Nagy; Ozlem Bozdagi; George W Huntley
Journal:  Learn Mem       Date:  2007-09-25       Impact factor: 2.460

Review 6.  Mast cells as early responders in the regulation of acute blood-brain barrier changes after cerebral ischemia and hemorrhage.

Authors:  Perttu Johannes Lindsberg; Daniel Strbian; Marja-Liisa Karjalainen-Lindsberg
Journal:  J Cereb Blood Flow Metab       Date:  2010-01-20       Impact factor: 6.200

7.  Clinical predictors and management of hemorrhagic transformation.

Authors:  Raphaella E Weiser; Kevin N Sheth
Journal:  Curr Treat Options Neurol       Date:  2013-04       Impact factor: 3.598

8.  Softening of the chronic hemi-section spinal cord injury scar parallels dysregulation of cellular and extracellular matrix content.

Authors:  Hannah J Baumann; Gautam Mahajan; Trevor R Ham; Patricia Betonio; Chandrasekhar R Kothapalli; Leah P Shriver; Nic D Leipzig
Journal:  J Mech Behav Biomed Mater       Date:  2020-06-30

Review 9.  Tissue-type plasminogen activator as a therapeutic target in stroke.

Authors:  Iordanis Gravanis; Stella E Tsirka
Journal:  Expert Opin Ther Targets       Date:  2008-02       Impact factor: 6.902

10.  Elevation of matrix metalloproteinases 3 and 9 in cerebrospinal fluid and blood in patients with severe traumatic brain injury.

Authors:  Mark Grossetete; Jeremy Phelps; Leopold Arko; Howard Yonas; Gary A Rosenberg
Journal:  Neurosurgery       Date:  2009-10       Impact factor: 4.654

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.